These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 6713865)

  • 1. Haemodialysis leucopenia as an index of membrane biocompatibility.
    Aljama P; Garin JM; Torres A; Martin-Malo A; Moreno E; Perez-Calderon R
    Contrib Nephrol; 1984; 37():129-33. PubMed ID: 6713865
    [No Abstract]   [Full Text] [Related]  

  • 2. Haemodialysis leucopenia: the role of membrane type and re-use.
    Hoenich NA; Johnston SR; Woffindin C; Kerr DN
    Contrib Nephrol; 1984; 37():120-8. PubMed ID: 6713864
    [No Abstract]   [Full Text] [Related]  

  • 3. Leukopenia and complement activation induced by different dialysis membranes.
    Man NK; Tien NQ; Lesavre P; Funck-Brentano JL
    Contrib Nephrol; 1984; 37():142-8. PubMed ID: 6713867
    [No Abstract]   [Full Text] [Related]  

  • 4. Membrane biocompatibility: clinical significance and therapeutic implications.
    Dumler F; Levin NW
    Int J Artif Organs; 1985 Sep; 8(5):257-62. PubMed ID: 3910591
    [No Abstract]   [Full Text] [Related]  

  • 5. Biocompatibility criteria in hemodialysis.
    Cordonnier DJ; Forêt M
    Contrib Nephrol; 1989; 71():30-5. PubMed ID: 2680263
    [No Abstract]   [Full Text] [Related]  

  • 6. Hypoxemia during hemodialysis: effect of different membranes and dialysate compositions.
    De Backer WA; Verpooten GA; Borgonjon DJ; Van Waeleghem JP; Vermeire PA; De Broe ME
    Contrib Nephrol; 1984; 37():134-41. PubMed ID: 6370588
    [No Abstract]   [Full Text] [Related]  

  • 7. [Mechanisms of acute leukopenia in hemodialysis. Role of direct leukocyte and dialyzer membrane interaction].
    Pacitti A; Segoloni G; Triolo G; Tetta C; Messina M; Bussolino F; Camussi G; Ragni R; Martini PF; Coppo R; Vercellone A
    Minerva Nefrol; 1980; 27(4):651-3. PubMed ID: 7254693
    [No Abstract]   [Full Text] [Related]  

  • 8. Blood-membrane interactions during haemodialysis with cellulose and synthetic membranes.
    Woffindin C; Hoenich NA
    Biomaterials; 1988 Jan; 9(1):53-7. PubMed ID: 3126842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Eicosanoid release as an indicator of membrane biocompatibility.
    Schultze G; Wagner K; Neumayer HH; Molzahn M
    Contrib Nephrol; 1987; 59():44-50. PubMed ID: 3442987
    [No Abstract]   [Full Text] [Related]  

  • 10. Complement activation and leucopenia on cellulosic haemodialyzers: influence of the membrane area and role of hydroxyl moieties.
    Goldman M; Lietaer N; Lambert P; Thayse C; Vanherweghem JL
    Life Support Syst; 1987; 5(4):317-22. PubMed ID: 3501504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Haemodialysis-induced leucopenia and activation of complement: effects of different membranes.
    Aljama P; Bird PA; Ward MK; Feest TG; Walker W; Tanboga H; Sussman M; Kerr DN
    Proc Eur Dial Transplant Assoc; 1978; 15():144-53. PubMed ID: 740661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leucopenia, hypoxia and complement activation in haemodialysis. Three unrelated phenomena.
    de Vinuesa SG; Resano M; Luño J; Gonzalez C; Barril G; Junco E; Valderrabano F
    Proc Eur Dial Transplant Assoc; 1983; 19():159-67. PubMed ID: 6878230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biocompatibility of different hemodialysis membranes: activation of complement and leukopenia.
    Wegmüller E; Montandon A; Nydegger U; Descoeudres C
    Int J Artif Organs; 1986 Mar; 9(2):85-92. PubMed ID: 3699914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biocompatibility of various dialysis membranes as assessed by coagulation assay.
    Gasparotto ML; Bertoli M; Vertolli U; Ruffatti A; Stoppa ML; Di Landro D; Romagnoli GF
    Contrib Nephrol; 1984; 37():96-100. PubMed ID: 6713885
    [No Abstract]   [Full Text] [Related]  

  • 15. Anaphylatoxin C5a generation and dialysis-induced leukopenia with different hemodialyzer membranes.
    Aljama P; Martín-Malo A; Castillo D; Velasco F; Torres A; Pérez R; Castro M
    Blood Purif; 1986; 4(1-3):88-92. PubMed ID: 3730166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of blood compatibility of haemodialysis membranes using a miniature flat sheet dialyser.
    Mwaniki DL; Courtney JM; Forbes CD; Paul JP
    East Afr Med J; 1992 Mar; 69(3):149-52. PubMed ID: 1505404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced biocompatibility with a new cellulosic membrane: Cuprophan versus Hemophan.
    Schaefer RM; Hörl WH; Kokot K; Heidland A
    Blood Purif; 1987; 5(4):262-7. PubMed ID: 3426830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abnormal leucocyte locomotion induced by haemodialysis membranes. A clue to dialysis leucopenia.
    Losito A; Buoncristiani U; Cecchini C
    J Clin Lab Immunol; 1983 Feb; 10(2):87-90. PubMed ID: 6601717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparison of biocompatibility of hemophane, cellulose diacetate and acrilonitile membranes in hemodialysis].
    Germin Petrović D
    Acta Med Croatica; 2004; 58(1):31-6. PubMed ID: 15125391
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vitamin E-bonded cellulose membrane and hemodialysis bioincompatibility: absence of an acute benefit on expression of leukocyte surface molecules.
    Dhondt A; Vanholder R; Glorieux G; Waterloos MA; De Smet R; Lesaffer G; Lameire N
    Am J Kidney Dis; 2000 Dec; 36(6):1140-6. PubMed ID: 11096038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.